NovoCure Ltd - Ordinary Shares, no par value per share (NVCR)

CUSIP: G6674U108

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 7 signals
Share change
+1,319,072
Put/Call ratio
34%
SEC-reported price per share
$41.50
Number of holders
255
Value change
+$42,388,515
Number of buys
102
Open additional details 1 more signal available
Number of sells
149
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
116,367,605

Security key

G6674U108

Report period

Q2 2023

Institutions

255

Top holders

10

Ownership snapshot

Top reported holders of NVCR - NovoCure Ltd - Ordinary Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Capital World Investors
Disclosed value leader
Capital World Investors
Comparable rows
0/15
Latest evidence
31 Mar 2023
13F Highest disclosed value: $843,457,648 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Capital World Investors has the largest disclosed position value at $843.46M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Capital World Investors's linked filing trail.
Disclosed position value Top 5
Capital World Investors $843.46M
VANGUARD GROUP INC $584.44M
BAILLIE GIFFORD & CO $517.41M
BlackRock Finance, Inc. $500.66M
Capital International Investors $459.99M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Capital World Investors
13F
Company
13F
—
denominator unverified
$843,457,648
14,025,057 shares
— 31 Mar 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$584,438,895
9,717,973 shares
— 31 Mar 2023
BAILLIE GIFFORD & CO
13F
Company
13F
—
denominator unverified
$517,414,551
8,603,501 shares
— 31 Mar 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$500,660,749
8,324,921 shares
— 31 Mar 2023
Capital International Investors
13F
Company
13F
—
denominator unverified
$459,991,502
7,648,987 shares
— 31 Mar 2023
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$166,622,782
2,770,608 shares
— 31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
255
Shares
90,419,824
Rows available
255
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
291
Q2 2023 holders
255
Holder diff
-36
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .